Načítá se...
SOMATOSTATIN RECEPTOR SUBTYPE 2A IMMUNOHISTOCHEMISTRY USING A NEW MONOCLONAL ANTIBODY SELECTS TUMORS SUITABLE FOR IN VIVO SOMATOSTATIN RECEPTOR TARGETING
High over-expression of somatostatin receptors in neuroendocrine tumors allows imaging and radiotherapy with radiolabelled somatostatin analogues. To know if a tumor is suitable for in vivo somatostatin receptor targeting, its somatostatin receptor expression has to be determined. There are specific...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3261429/ https://ncbi.nlm.nih.gov/pubmed/22251942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0b013e31823d07f3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|